BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32960279)

  • 1. Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
    Wang T; Mott N; Miller J; Berlin NL; Hawley S; Jagsi R; Dossett LA
    JAMA Netw Open; 2020 Sep; 3(9):e2017129. PubMed ID: 32960279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
    Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
    JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.
    Wang T; Baskin A; Miller J; Metz A; Matusko N; Hughes T; Sabel M; Jeruss JS; Dossett LA
    Ann Surg Oncol; 2021 Feb; 28(2):902-913. PubMed ID: 32651693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer.
    Minami CA; Bryan AF; Freedman RA; Revette AC; Schonberg MA; King TA; Mittendorf EA
    JAMA Netw Open; 2022 Aug; 5(8):e2228524. PubMed ID: 36001314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Maximizing-Minimizing Preferences in Relation to Low-Value Services for Older Women with Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
    Mott N; Wang T; Miller J; Berlin NL; Hawley S; Jagsi R; Zikmund-Fisher BJ; Dossett LA
    Ann Surg Oncol; 2021 Feb; 28(2):941-949. PubMed ID: 32720038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaps in Online Breast Cancer Treatment Information for Older Women.
    Baskin AS; Wang T; Mott NM; Hawley ST; Jagsi R; Dossett LA
    Ann Surg Oncol; 2021 Feb; 28(2):950-957. PubMed ID: 32734367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Tailored Messages to Target Overuse of Low-Value Breast Cancer Care in Older Women.
    Dossett LA; Mott NM; Bredbeck BC; Wang T; Jobin CT; Hughes TM; Hawley ST; Zikmund-Fisher BJ
    J Surg Res; 2022 Feb; 270():503-512. PubMed ID: 34801801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor-Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative.
    Wright JL; Parekh A; Pollock YY; Schoenborn N; Smith KL; Magnant C; Stearns V
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):884-890. PubMed ID: 28366577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).
    Houvenaeghel G; Lambaudie E; Cohen M; Classe JM; Reyal F; Garbay JR; Giard S; Chopin N; Martinez A; Rouzier R; Daraï E; Colombo PE; Coutant C; Gimbergues P; Azuar P; Villet R; Tunon de Lara C; Barranger E; Sabiani L; Goncalves A
    Breast; 2017 Aug; 34():24-33. PubMed ID: 28475932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Treatment Decision-Making in Older Women With Breast Cancer: A Survey-Based Study.
    Kazemi RJ; VanWinkle C; Pesavento CM; Wang T; Dossett LA
    J Surg Res; 2024 Apr; 296():418-424. PubMed ID: 38320360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Matar R; Barrio AV; Sevilimedu V; Le T; Heerdt A; Morrow M; Tadros A
    Ann Surg Oncol; 2022 Apr; 29(4):2263-2272. PubMed ID: 34994896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
    Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
    Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
    Hunt KK; Ballman KV; McCall LM; Boughey JC; Mittendorf EA; Cox CE; Whitworth PW; Beitsch PD; Leitch AM; Buchholz TA; Morrow MA; Giuliano AE
    Ann Surg; 2012 Sep; 256(3):428-36. PubMed ID: 22868365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
    Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D
    JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
    Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
    Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer.
    Christian N; Heelan Gladden A; Friedman C; Gleisner-Patton A; Murphy C; Kounalakis N; Ahrendt G
    Breast J; 2020 Feb; 26(2):133-138. PubMed ID: 31448508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.